The benefits of mid-luteal addition of human chorionic gonadotrophin in in-vitro fertilization using a downregulation protocol and luteal support with progesterone

Human Reproduction

Volumn 11, Issue 7, 1996, Pages 1552-1557

  Herman, Arie ^a   Raziel, Arie ^a   Strassburger, Debora ^a   Soffer, Yigal ^a   Bukovsky, Ian ^a   Ron El, Raphael ^a  

^a TEL AVIV UNIVERSITY   (Israel)

Author keywords

Corpus luteum; GnRHa; HCG; IVF; Luteal phase; Progesterone

Indexed keywords

CHORIONIC GONADOTROPIN; CHORIONIC GONADOTROPIN BETA SUBUNIT; ESTRADIOL; PROGESTERONE;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORPUS LUTEUM FUNCTION; EMBRYO TRANSFER; ESTRADIOL BLOOD LEVEL; FEMALE; FEMALE INFERTILITY; FERTILIZATION IN VITRO; HUMAN; INTRAMUSCULAR DRUG ADMINISTRATION; LUTEAL PHASE; MAJOR CLINICAL STUDY; OVARY DISEASE; PREGNANCY COMPLICATION; PREGNANCY RATE; PROGESTERONE BLOOD LEVEL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL;

EID: 0029834995     PISSN: 02681161     EISSN: None     Source Type: Journal    
DOI: 10.1093/oxfordjournals.humrep.a019436     Document Type: Article

References (19)

1. Balasch, J., Fabregues, F., Tur, R. et al. (1995) Further characterization of the luteal phase inadequacy after gonadotrophin-releasing hormone agonist-induced ovulation in gonadotrophin-stimulated cycles. Hum. Reprod., 10, 1377-1381.
2. Belaisch-Allart, J., De Mouzon, J., Lapousterle, C. and Mayer, M. (1990) The effect of HCG supplementation after combined GnRH agonist/HMG treatment in an IVF programme. Hum. Reprod., 5, 163-166.
3. Buvat, J., Marcolin, G., Guittard, C. et al. (1990) Luteal support after luteinizing hormone-releasing hormone agonist for in vitro fertilization: superiority of human chorionic gonadotropin over oral progesterone. Fertil. Steril., 53, 490-494.
4. Claman, P., Domingo, M. and Leader, A. (1992) Luteal phase support in in-vitro fertilization using gonadotrophin releasing hormone analogue before ovarian stimulation: a prospective randomized study of human chorionic gonadotrophin versus intramuscular progesterone. Hum. Reprod., 7, 487-489.
5. Confino, E., Demir, R.H., Friberg, J. and Gleicher, N. (1986) The predictive value of hCG β subunit levels in pregnancies achieved by in vitro fertilization and embryo transfer: an international collaborative study. Fertil. Steril., 45, 526-531.
6. Forman, R.G., Frydman, R., Egan, D. et al. (1990) Severe ovarian hyperstimulation syndrome using agonists of gonadotrophin-releasing hormone for in vitro fertilization: a European series and proposals for prevention. Fertil. Steril., 53, 502-509.
7. Golan, A., Herman, A., Soffer, Y. et al. (1993) Human chorionic gonadotrophin is a better luteal support than progesterone in ultrashort gonadotrophin-releasing hormone agonist/menotrophin in-vitro fertilization cycles. Hum. Reprod., 8, 1372-1375.
8. Herman, A., Ron-El, R., Golan, A. et al. (1990) Pregnancy rate and ovarian hyperstimulation after luteal human chorionic gonadotropin in IVF stimulated with GnRH analog and menotropins. Fertil. Steril., 53, 92-96.
9. Hutchinson-Williams, K.A., DeCherney, A.H., Lavy, G. et al. (1990) Luteal rescue in in vitro fertilization-embryo transfer. Fertil. Steril., 53, 495-501.
10. Lenton, E.A., Neal, L.M. and Sulaiman, R. (1982) Plasma concentrations of human chorionic gonadotrophin from the time of implantation until the second week of pregnancy. Fertil. Steril., 37, 773-778.
11. Lockwood, G.M., Pinkerton, S.M. and Barlow, D.H. (1995) A prospective randomized single-blind comparative trial of nafarelin acetate with buserelin in long-protocol gonadotrophin-releasing hormone analogue controlled in-vitro fertilization cycles. Hum. Reprod., 10, 293-298.
12. Meldrum, D.R., Wisot, A., Hamilton, F. et al. (1989) Routine pituitary suppression with leuprolide before ovarian stimulation for oocyte retrieval. Fertil. Steril., 51, 455-459.
13. Rizk, B. and Smitz, J. (1992) Ovarian hyperstimulation syndrome after superovulation using GnRH agonists for IVF and related procedures. Hum. Reprod., 7, 320-327.
14. Smith, E.M., Anthony, F.W., Gadd, S.C. and Masson, G.M. (1989) Trials of support treatment with human chorionic gonadotrophin in the luteal phase after treatment with buserelin and human menopausal gonadotrophin in women taking part in an in vitro fertilisation programme. Br. Med. J., 298, 1483-1486.
15. Smitz, J., Devroey, P., Braeckmans, P. et al. (1987) Management of failed cycles in an IVF/GIFT programme with the combination of a GnRH analogue and HMG. Hum. Reprod., 2, 309-314.
16. Smitz, J., Devroey, P., Camus, M. et al. (1988) The luteal phase and early pregnancy after combined GnRH-agonist/HMG treatment for superovulation in IVF or GIFT. Hum. Reprod, 3, 585-590.
17. Smitz, J., Bourgain, C., Van Waesberghe, L. et al. (1993) A prospective randomized study on oestradiol valerate supplementation in addition to intravaginal micronized progesterone in buserelin and HMG induced superovulation. Hum. Reprod., 8, 40-45.
18. Soliman, S., Daya, S., Collins, J. and Hughes, E.G. (1994) The role of luteal phase support in infertility treatment: a meta-analysis of randomized trials. Fertil. Steril., 61, 1068-1076.
19. Van Steirteghem, A.C., Smitz, J., Camus, M. et al. (1988) The luteal phase after in-vitro fertilization and related procedures. Hum. Reprod., 3, 161-164.